{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:45:58Z","timestamp":1784213158317,"version":"3.55.0"},"reference-count":32,"publisher":"BMJ","issue":"9","funder":[{"name":"Fonds de perfectionnement du Centre Hospitalier Universitaire Vaudois"},{"name":"Ligue Pulmonaire Vaudoise"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2022,11,1]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Non-exacerbating patients with chronic obstructive pulmonary disease (COPD) are a less studied phenotype. We investigated clinical characteristics, mortality rates and causes of death among non-exacerbating compared with exacerbating patients with COPD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data from the Clinical Practice Research Datalink, Hospital Episode Statistics and Office for National Statistics between 1 January 2004 and 31 December 2018. Ever smokers with a COPD diagnosis with minimum 3 years of baseline information were included. We compared overall using Cox regression and cause-specific mortality rates using competing risk analysis, adjusted for age, sex, deprivation, smoking status, body mass index, GOLD stage and comorbidities. Causes of death were identified using International Classification of Diseases-10 codes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 67 516 patients, 17.3% did not exacerbate during the 3-year baseline period. Mean follow-up was 4 years. Non-exacerbators were more likely to be male (63.3% vs 52.4%, p&lt;0.001) and less often had a history of asthma (33.9% vs 43.6%, p&lt;0.001) or FEV<jats:sub>1<\/jats:sub>&lt;50% predicted (23.7 vs 31.8%) compared with exacerbators. Adjusted HR for overall mortality in non-exacerbators compared with exacerbators was 0.62 (95% CI 0.56 to 0.70) in the first year of follow-up and 0.87 (95% CI 0.83 to 0.91) thereafter. Non-exacerbating patients with COPD died less of respiratory causes than exacerbators (29.2% vs 40.3%) and more of malignancies (29.4% vs 23.4%) and cardiovascular diseases (26.2% vs 22.9%). HRs for malignant and circulatory causes of death were increased after the first year of follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In this primary care cohort, non-exacerbators showed distinct clinical characteristics and lower mortality rates. Non-exacerbators were equally likely to die of respiratory, malignant or cardiovascular diseases.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2022-218724","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:41:09Z","timestamp":1669315269000},"page":"904-911","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data"],"prefix":"10.1136","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-6507","authenticated-orcid":false,"given":"Alexandra","family":"Lenoir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-3896","authenticated-orcid":false,"given":"Debbie","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-4869","authenticated-orcid":false,"given":"Jennifer K","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"2024051320291200000_78.9.904.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00124605"},{"key":"2024051320291200000_78.9.904.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61377-4"},{"key":"2024051320291200000_78.9.904.3","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.5.388"},{"key":"2024051320291200000_78.9.904.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212514"},{"key":"2024051320291200000_78.9.904.5","unstructured":"British Lung Foundation . Chronic obstructive pulmonary disease (COPD) statistics, 2021. Available: https:\/\/statistics.blf.org.uk\/copd [Accessed 26 Sep 2021]."},{"key":"2024051320291200000_78.9.904.6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the global burden of disease study 2015","volume":"5","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024051320291200000_78.9.904.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61382-8"},{"key":"2024051320291200000_78.9.904.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4680"},{"key":"2024051320291200000_78.9.904.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1843CC"},{"key":"2024051320291200000_78.9.904.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"2024051320291200000_78.9.904.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201710-2029OC"},{"key":"2024051320291200000_78.9.904.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01446-2016"},{"key":"2024051320291200000_78.9.904.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00214-2017"},{"key":"2024051320291200000_78.9.904.14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","article-title":"Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort","volume":"5","author":"Han","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024051320291200000_78.9.904.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0442-4"},{"key":"2024051320291200000_78.9.904.16","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2024051320291200000_78.9.904.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005540"},{"key":"2024051320291200000_78.9.904.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151357"},{"key":"2024051320291200000_78.9.904.19","unstructured":"World Health Organisation . Classification of diseases (ICD), 2019. Available: https:\/\/icd.who.int\/browse10\/2019\/en [Accessed 26 Sep 2021]."},{"key":"2024051320291200000_78.9.904.20","unstructured":"Office for National Statistics (ONS) . User guide to mortality statistics: office for national statistics, 2021. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/methodologies\/userguidetomortalitystatisticsjuly2017 [Accessed 26 Sep 2021]."},{"key":"2024051320291200000_78.9.904.21","unstructured":"Department for Communities and Local Government . The English indices of deprivation 2015: statistical release; 2015, 2015. Available: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015 [Accessed 29 Sep 2021]."},{"key":"2024051320291200000_78.9.904.22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party standardization of lung function tests, European community for steel and coal. official statement of the European respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"2024051320291200000_78.9.904.23","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . 2020 gold reports. Available: https:\/\/goldcopd.org\/gold-reports\/ [Accessed 18 Sep 2021]."},{"key":"2024051320291200000_78.9.904.24","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201518"},{"key":"2024051320291200000_78.9.904.25","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.10.847"},{"key":"2024051320291200000_78.9.904.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.03.035"},{"key":"2024051320291200000_78.9.904.27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","article-title":"Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life","volume":"6","author":"Bui","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024051320291200000_78.9.904.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411532"},{"key":"2024051320291200000_78.9.904.29","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0573-0"},{"key":"2024051320291200000_78.9.904.30","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00008612"},{"key":"2024051320291200000_78.9.904.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2029"},{"key":"2024051320291200000_78.9.904.32","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.027946"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-218724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:45:36Z","timestamp":1715658336000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-218724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,8,16]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/thorax-2022-218724"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-218724","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]}}}